This study employs perfusion and diffusion weighted imaging (PDWI) at 21.1 T to identify the pattern of potential recovery of cerebral blood flow (CBF) and apparent diffusion coefficient (ADC) in ischemic stroke with a novel stem cell therapy using dissociated aggregate human mesenchymal stem cells (d-hMSC) in a rodent stroke model. Spanning a week post ischemia, high field MRI was performed with the goal of quantitatively assessing treatment efficacy longitudinally. Results show longer term increase of ADC in the ischemic region and shorter term CBF stabilization in the contralateral region.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords